Injured erythrocytes release adenosine deaminase into the circulation

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1250-1260

  Jackson, Edwin K ^a   Mi, Zaichuan ^a   Koehler, Maria T ^a   Carcillo Jr , Joseph A ^a   Herzer, William A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE DEAMINASE; DIMETHYL SULFONE; DIMETHYL SULFOXIDE;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DAMAGE; ENZYME ACTIVITY; ENZYME RELEASE; ERYTHROCYTE; HEMOGLOBINURIA; MALE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RAT; SICKLE CELL ANEMIA; VASOCONSTRICTION;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIMETHYL SULFOXIDE; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; KIDNEY; MALE; PURINES; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ULTRAVIOLET; SPLENECTOMY;

EID: 0030425687     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. ALBINO-TEIXEIRA, A., MATIAS, A., POLONIA, J. AND AZEVEDO, I.: Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J. Hyper. 9: S196-S197, 1991.
2. ANDY, R. J. AND KORNFELD, R.: The adenosine deaminase binding protein of human skin fibroblasts is located on the cell surface. J. Biol. Chem. 257: 7922-7925, 1982.
3. ARCH, J. R. AND NEWSHOLME, E. A.: Activities and some properties of adenylate cyclase and phosphodiesterase in muscle, liver and nervous tissues from vertebrates and invertebrates in relation to the control of the concentration of adenosine 3′:5′-cyclic monophosphate. Biochem. J. 158: 603-622, 1976.
4. CHURCHILL, P. C. AND BIDANI, A.: Renal effects of selective adenosine receptor agonists in anesthetized rats. Am. J. Physiol. 252: F299-F303, 1987.
5. 2 adenosine receptor activation inhibits and stimulates renin secretion of rat renal cortical slices. J. Pharmacol. Exp. Ther. 232: 589-594, 1985.
6. CONNOR, K. W. AND ASHWOOD-SMITH, M. J.: Ineffectiveness of dimethylsulfone as a cryoprotectant agent. Crybiology 10: 87-88, 1973.
7. CRISTALLI, G., VITTORI, S., THOMPSON, R. D., PADGETT, W. L., SHI, D., DALY, J. W. AND OLSSON, R. A.: Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 349: 644-650, 1994.
8. CRONSTEIN, B. N.: Adenosine, an endogenous anti-inflammatory agent. J. Applied. Physiol. 76: 5-13, 1994.
9. DADDONA, P. E. AND KELLEY, W. N.: Human adenosine deaminase: Purification and subunit structure. J. Biol. Chem. 252: 110-115, 1977.
10. DAEMEN, M. J., LOMBARDI, D. M., BOSMAN, F. T. AND SCHWARTZ, S. M.: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res. 68: 450-456, 1991.
11. DALZIEL, H. H. AND WESTFALL, D. P.: Receptors for adenine nucleotides and nucleosides: Subclassification, distribution, and molecular characterization. Pharmacol. Rev. 46: 449-466, 1994.
12. DE BRUIJNE, A. W. AND VAN STEVENINCK, J.: The influence of dimethylsulfoxide on the red cell membrane. Biochem. Pharmacol. 23: 3247-3258, 1974.
13. DE MEY, J., BURNSTOCK, G. AND VANHOUTTE, P. M.: Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP. Eur. J. Pharmacol. 55: 401-405, 1976.
14. DUBEY, R. K., GILLESPIE, D. G., MI, Z., SUZUKI, F. AND JACKSON, E. K.: Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension 27: 766-773, 1996b.
15. 2b receptor. Hypertension 27: 786-793, 1996a.
16. 1 receptors. J. Clin. Invest. 96: 141-149, 1995.
17. EKAS, R. D. JR., STEENBERG, M. L., EIKENBURG, D. C. AND LOKHANDWALA, M. F.: Presynaptic inhibition of sympathetic neurotransmission by adenosine in the rat kidney. Eur. J. Pharmacol. 76: 301-307, 1981.
18. ENERO, M. A. AND SAIDMAN, B. Q.: Possible feed-back inhibition of noradrenaline release by purine compounds. Naunyn-Schmiedeberg's Arch. Pharmacol. 297: 39-46, 1977.
19. FEENER, E. P., NORTHHUP, J. M., AIELLO, L. P. AND KING, G. L.: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J. Clin. Invest. 95: 1353-1362, 1995.
20. 2 dopamine receptors in rat striaturn. Mol. Brain. Res. 14: 186-195, 1992.
21. GEIGER, J. D., PADUA, R. A. AND NAGY, J. I.: Adenosine deaminase regulation of purine actions. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function, ed. by J. W. Phillis, pp. 71-84, CRC Press/Boca Raton, 1991.
22. GUIMARAES, S., ALBINO-TEIXEIRA, A. AND PAIVA, M. Q.: Hypertension and enhanced beta-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors. Br. J. Pharmacol. 114: 1595-1598, 1995.
23. HEADRICK, J. P. AND BERNE, R. M.: Endothelium-dependent and -independent relaxations to adenosine in guinea pig aorta. Am. J Physiol. 259: H62-H67, 1990.
24. HEDQVIST, P. AND FREDHOLM, B. B.: Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and post-junctional enhancement. Naunyn-Schmiedeberg's Arch. Pharmacol. 293: 217-223, 1976.
25. HERTZ, L.: Nucleoside transport in cells: Kinetics and inhibitor effects. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function, ed. by J. W. Phillis, pp. 85-107, CRC Press/Boca Raton 1991.
26. ITOH, H., MUKOYAMA, M., PRATT, R. E., GIBBONS, G. H. AND DZAU, V. J.: Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest. 91: 2268-2274, 1993.
27. JACKSON, E. K., KOEHLER, M., MI, Z., DUBEY, R. K., TOFOVIC, S. P., CARCILLO, J. A. AND JONES, G. S.: Possible role of adenosine deaminase in vaso-occlusive diseases. Journal of Hypertension 14: 19-29, 1996.
28. JACOB, S. W. AND HERSCHLER, R.: Pharmacology of DMSO. Cryobiology 23: 14-27, 1986.
29. 1 adenosine receptor. EMBO. J. 10: 1677-1682, 1991.
30. 1 adenosine receptors in the rabbit heart. Circulation 84: 350-356, 1991.
31. MAENHAUT, C., VAN SANDE, J., LIBERT, F., ABRAMOWICZ, M., PARMENTIER, M., VANDERHAEGEN, J. J., DUMONT, J. E., VASSART, G. AND SCHIFFMANN, S.: RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem. Biophys. Res. Commun. 173: 1169-1178, 1990.
32. MAGGIRWAR, S. B., DHANRAJ, D. N., SOMANI, S. M. AND RAMKUMAR, V.: Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem. Biophys. Res. Commun. 201: 508-515, 1994.
33. 1 adenosine receptor from rat brain. Mol. Pharmacol. 40: 1-7, 1991.
34. MEGHJI, P., MIDDLETON, K., HASSALL, C. J. S., PHILLIPS, M. I. AND NEWBY, A. C.: Evidence for extracellular deamination of adenosine in the rat heart. Int. J. Biochem. 20: 1335-1341, 1988.
35. MURRAY, R. D. AND CHURCHILL, P. D.: Effects of adenosine receptor agonists in the isolated, perfused rat kidney. Am. J. Physiol. 247: H343-H348, 1984.
36. MURRAY, R. D. AND CHURCHILL, P. C.: Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists. J. Pharmacol. Exp. Ther. 232: 189-193, 1985.
37. NORRED, W. P., ANSEL, H. C., ROTH, I. L. AND PEIFER, J. J.: Mechanism of dimethyl sulfoxide-induced hemolysis. J. Pharm. Sci. 59: 618-622, 1970.
38. OLAH, M. E. AND STILES, G. L.: Adenosine receptor subtypes: Characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35: 581-606, 1995.
39. 2b receptor from human brain. Biochem. Biophys. Res. Commun. 187: 86-93, 1992.
40. 2b-adenosine receptor. Mol. Endocrinol. 6: 1598-1604, 1992.
41. RUBINO, A. AND BURNSTOCK, G.: Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylx-anthine-induced hypertension. J. Pharmacol. Exp. Ther. 275: 422-428, 1995.
42. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 90: 10365-10369, 1993.
43. SCHRADER, J.: Formation and metabolism of adenosine and adenine nucleotides in cardiac tissue. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function, ed. by J. W. Phillis, pp. 55-69, CRC Press/Boca Raton, 1991.
44. SCOTT-BURDEN, T., HAHN, A. W., RESINK, T. J. AND BUHLER, F. R.: Modulation of extracellular matrix by angiotensin II: Stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J. Cardiovasc. Pharmacol, 16: S36-S41, 1990.
45. SHARFF, A. J., WILSON, D. K., CHANG, Z. AND QUIOCHO, F. A.: Refined 2.5 Å structure of murine adenosine deaminase at pH 6.0. J. Mol. Biol. 226: 917-921, 1992.
46. STEINHORN, R. H., MORIN, F. C., 3RD, VAN WYLEN, D. G. L., GUGINO, S. F., GIESE, E. C. AND RUSSELL, J. A.: Endothelium-dependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins. Am. J. Physiol. 266: H2001-H2006, 1994.
47. SUNG, C. P., ARLETH, A. J., STORER, B. L. AND OHLSTEIN, E. H.: Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J. Pharmacol. Exp. Ther. 271: 429-437, 1994.
48. VAUGHAN, D. E., LAZOS, S. A. AND TONG, K.: Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J. Clin. Invest. 95: 995-1001, 1995.
49. VIALS, A. AND BURNSTOCK, G.: A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: A role for nitric oxide. Br. J. Pharmacol. 109: 424-429, 1993.
50. WILLIS, E. H., CARSON, D. A. AND SHULTZ, L. D.: Adenosine deaminase activity in recipients of bone marrow from immunodeficient mice homozygous for the wasted mutation. Biochem. Biophys. Res. Comm. 145: 581-585, 1987.
51. WOOD, D. C. AND WOOD, J.: Pharmacologic and biochemical considerations of dimethyl sulfoxide. Ann. N. Y. Acad. Sci. 243: 7-19, 1975.
52. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 89: 7432-7436, 1992.
53. ZHU, Q., MATHERNE, G. P., CURNISH, R. R., TRIBBLE, C. G. AND BERNE, R. M.: Effect of adenosine deaminase on cardiac interstitial adenosine. Am. J. Physiol. 263: H1322-H1326, 1992.